Cargando…
Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2?
Commentary on 'Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19' by Sun et al.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326129/ https://www.ncbi.nlm.nih.gov/pubmed/34345206 http://dx.doi.org/10.7150/ijbs.63969 |
| Sumario: | Commentary on 'Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19' by Sun et al. |
|---|